Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neridronic Acid in Complex Regional Pain Syndrome (CRPS)
NCT03560986Phase 3Terminated
- Sponsor
- Grünenthal GmbH
- Start
- May 2018
- Primary completion
- Aug 2019
- Modality
- Orthosteric Ligands
- Countries
- 7
01
Overview
A Phase 3 trial of neridronic acid in complex regional pain syndrome (CRPS), sponsored by Grünenthal GmbH. Started May 2018; status: terminated.
02
Drugs
neridronic acid
03
Conditions
complex regional pain syndrome (CRPS)
Beyond the preview
Go deeper on NCT03560986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03560986.